Show
Sort by
-
Carbohydrate-binding agents (CBAs) inhibit HIV-1 infection in human primary monocyte-derived macrophages (MDMs) and efficiently prevent MDM-directed viral capture and subsequent transmission to CD4(+) T lymphocytes
-
Carbohydrate-binding agents (CBAs) potently inhibit HIV infection in human primary monocytes/macrophages and efficiently prevent viral capture and subsequent transmission to CD+4 T lymphocytes
-
Entry of hepatitis C virus and human immunodeficiency virus is selectively inhibited by carbohydrate-binding agents but not by polyanions
-
Carbohydrate-binding agents (CBAs) selectively target the glycoproteins of the HCV and HIV envelope to prevent viral entry
-
Mutational pathways, resistance profile, and side effects of cyanovirin relative to human immunodeficiency virus type 1 strains with N-glycan deletions in their gp120 envelopes
-
Carbohydrate-binding agents cause deletions of highly conserved glycosylation sites in HIV GP120 - A new therapeutic concept to hit the Achilles heel of HIV
-
Marked depletion of glycosylation sites in HIV-1 gp120 under selection pressure by the mannose-specific plant lectins of Hippeastrum hybrid and Galanthus nivalis
-
Pro-inflammatory properties of stromal cell-derived factor-1 (CXCL12) in collagen-induced arthritis
-
Profile of resistance of human immunodeficiency virus to mannose-specific plant lectins
-
Mannose-specific plant lectins from the Amaryllidaceae family qualify as efficient microbicides for prevention of human immunodeficiency virus infection
-
IL-2 reverses human T-cell unresponsiveness induced by thymic epithelium in SCID-HU mice
-
In-vivo cytokine expression in the thymus CD3(high) human thymocytes are activated and already functionally differentiated in helper and cytotoxic-cells
-
Human IG production and isotype switching in severe combined immunodeficient: human mice